Order Article Reprints

Bates EA, Kipp ZA, Martinez GJ, Badmus OO, Soundarapandian MM, Foster D, Xu M, Creeden JF, Greer JR, Morris AJ, et al. Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease. Biomolecules. 2023; 13(2):252. https://doi.org/10.3390/biom13020252

Bates, Evelyn A., Zachary A. Kipp, Genesee J. Martinez, Olufunto O. Badmus, Mangala M. Soundarapandian, Donald Foster, Mei Xu, Justin F. Creeden, Jennifer R. Greer, Andrew J. Morris, and et al. 2023. "Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease" Biomolecules 13, no. 2: 252. https://doi.org/10.3390/biom13020252

Bates, E. A., Kipp, Z. A., Martinez, G. J., Badmus, O. O., Soundarapandian, M. M., Foster, D., Xu, M., Creeden, J. F., Greer, J. R., Morris, A. J., Stec, D. E., & Hinds, T. D., Jr. (2023). Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease. Biomolecules, 13(2), 252. https://doi.org/10.3390/biom13020252